Stage IVA Prostate Cancer AJCC v8 Withdrawn Phase 1 / 2 Trials for Decitabine (DB01262)

IndicationStatusPhase
DBCOND0109674 (Stage IVA Prostate Cancer AJCC v8)Withdrawn1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03709550Enzalutamide and Decitabine in Treating Patients With Metastatic Castration Resistant Prostate CancerTreatment